Interferon-γ induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cells - Feld - 2010 - Experimental Dermatology - Wiley Online Library
Links shared publicly online about this topic.
- 864total visits
Interferon-γ induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cells - Feld - 2010 - Experimental Dermatology - Wiley Online Library
View full resource at onlinelibrary.wiley.com
Tags: Dermatology
Most Recently Shared on September 18, 2010 at 2:24 pm By:
Interferonâ€*γ induces upregulation and activation of the interleukinâ€*31 receptor in human dermal microvascular... http://bit.ly/bfgvPj
Manage Account - ModernMedicine
modernmedicine.com — “NEW YORK (Reuters Health) - Interferon-gamma release assays (IGRAs) are significantly better than tuberculin skin tests (TST) at predicting progression from latent tuberculosis (TB), a new meta-analysis from Germany shows.” View full resource at modernmedicine.com
Most Recently Shared on May 10, 2012 at 9:34 pm By:
Interferon-gamma release assays better for TB testing http://t.co/G9FRAoBs #dermatology
ingentaconnect Rapid diagnosis of Mycobacterium tuberculosis infection in childr...
ingentaconnect.com — “ingentaconnect Rapid diagnosis of Mycobacterium tuberculosis infection in childr...” View full resource at ingentaconnect.com
Most Recently Shared on May 10, 2012 at 5:06 pm By:
Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs... http://t.co/3e3Dv80H
Patient Trial For New Asthma Treatment Yields Positive Results
medicalnewstoday.com — “Scientists from the University of Southampton and Synairgen, a respiratory drug development company spun out from the University, can announce positive data from its Phase II clinical trial, into” View full resource at medicalnewstoday.com
Most Recently Shared on April 21, 2012 at 7:05 am By:
Patient Trial For New Asthma Treatment Yields Positive Results http://t.co/L0EvtrID #viruses #bacteria
Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS
eurekalert.org — “People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21-28, 2012.” View full resource at eurekalert.org
Most Recently Shared on April 20, 2012 at 7:17 am By:
Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS: ( American Acade... http://t.co/DJO0pAcf
Early Use of MS Drug May Cut Likelihood of Progression --Doctors Lounge
doctorslounge.com — “Early Use of MS Drug May Cut Likelihood of Progression --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on April 19, 2012 at 9:27 pm By:
Early Use of MS Drug May Cut Likelihood of Progression: Study found fewer people given 'interferon beta-1a' earl... http://t.co/QoQs8sY7
Early Use of MS Drug May Cut Likelihood of Progression --Doctors Lounge
doctorslounge.com — “Early Use of MS Drug May Cut Likelihood of Progression --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on April 19, 2012 at 9:06 pm By:
Early Use of MS Drug May Cut Likelihood of Progression http://t.co/37ykQFu5 #health #medicine
Interferon-Free Hepatitis C Trial Achieves 82% Viral Cure
medicalnewstoday.com — “According to new data from the largest Phase II interferon-free trial to date, after only 28 weeks of treatment, almost 82% of hepatitis C patients achieved a viral cure. The results were achieve” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2012 at 8:05 pm By:
Interferon-Free Hepatitis C Trial Achieves 82% Viral Cure http://t.co/PMIB5efb #healthnews
HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 4:12 pm By:
EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the… http://t.co/es8fhWgM
HCV New Drug Research: EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 4:12 pm By:
EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis… http://t.co/p3KdpuhG
HCV New Drug Research: EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNER
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNER” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 3:10 pm By:
EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNER http://t.co/4I9kPBDl
Clinical Neurology News - January 2012 - (12)
nxtbook.com — “Digital Edition” View full resource at nxtbook.com
Most Recently Shared on March 31, 2012 at 2:26 am By:
MS Activity Returns After Stopping Natalizumab http://t.co/OfzsriaQ
MedWire News - Infectious Diseases - Human gene variant can transform mild flu into serious disease
medwire-news.md — “MedWire News People with a specific variant of the interferon-inducible transmembrane 3 gene are more likely to be hospitalized with seasonal or pandemic influenza than noncarriers, suggest study results published in Nature. MedWire News” View full resource at medwire-news.md
Most Recently Shared on March 26, 2012 at 1:30 pm By:
Human gene variant can transform mild flu into serious disease http://t.co/mPbJZlLN
Endocrinology News - Low Density Lipoprotein Apheresis Ameliorates Interferon- Production in Patients With Nephrotic Syndrome |3966075
mdlinx.com — “Endocrinology Medical Article: Low Density Lipoprotein Apheresis Ameliorates Interferon- Production in Patients With Nephrotic Syndrome” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 6:52 am By:
Low Density Lipoprotein Apheresis Ameliorates Interferon- Production in Patients With Nephrotic Syndrome: ... http://t.co/rT4osgTS #endo
Early predictors of non-response to interferon in multiple sclerosis - Horakova - 2012 - Acta Neurologica Scandinavica - Wiley Online Library
onlinelibrary.wiley.com — “Early predictors of non-response to interferon in multiple sclerosis - Horakova - 2012 - Acta Neurologica Scandinavica - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 17, 2012 at 1:11 am By:
Early predictors of non‐response to interferon in multiple sclerosis: ConclusionsIn patients with MS treated wit... http://t.co/33hqr76W
Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts
rheumatology.oxfordjournals.org — “Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts” View full resource at rheumatology.oxfordjournals.org
Most Recently Shared on March 17, 2012 at 1:11 am By:
Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with ... http://t.co/pn3yTm18
Advertisement

